1. Volume 82, Issue 3, Pages 330-337 (August 2012)
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers 
Hiddo J. Lambers Heerspink, Frank A. Holtkamp, Hans-Henrik Parving, Gerjan J. Navis, Julia B. Lewis, Eberhard Ritz, Pieter A. de Graeff, Dick de Zeeuw 
Kidney International 
Volume 82, Issue 3, Pages (August 2012)
DOI: /ki
Copyright © 2012 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan–Meier curves according to tertiles of 24-h urinary sodium/creatinine ratio. Kaplan–Meier curves for (a) renal and (b) cardiovascular events in subjects who received angiotensin receptor blocker (ARB)– and non-renin–angiotensin–aldosterone system (non-RAASi)–based therapy stratified by tertiles of 24-h sodium/creatinine ratio: <121mmol/g; 121–153mmol/g; ≥153mmol/g.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

3. Figure 2
Effect of angiotensin receptor blocker (ARB) treatment vs. non-renin–angiotensin–aldosterone system (non-RAASi)–based treatment on the risk for renal and cardiovascular outcomes according to tertiles of 24-h urinary sodium/creatinine ratio. The center of the diamond represents the overall estimate, and the width represents its 95% confidence interval (CI). Solid boxes represent estimates of treatment effects in subgroups, and the horizontal line represents the 95% CI. ESRD, end-stage renal disease.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

4. Figure 3
Mean estimated glomerular filtration rate (eGFR) levels through 30 months among patients who were assigned to receive angiotensin receptor blocker (ARB) or non-renin–angiotensin–aldosterone system (non-RAASi)–based therapy by tertiles of 24-h sodium/creatinine ratio.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions